FiercePharma2h
Wegovy and Zepbound tipped to fuel $20B boom in heart failure market
GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...
Ozempic ‘microdosing’ is gaining popularity — but is it effective?
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.
NBC News13h
Tennessee woman accused of selling fake weight loss drugs as counterfeit concerns grow
Counterfeit versions of Wegovy or Zepbound are different from compounded weight loss drugs. Compounding is a legitimate practice that’s monitored by the Food and Drug Administration. Compounded ...
Today7d
Is Ozempic safe for weight loss? What doctors want you to know
GLP-1 drugs — which include Ozempic and its sister drug Wegovy, as well as Mounjaro and Zepbound — mimic at least one hormone produced by the gut to signal fullness, leading to a reduced appetite.
dailymemphian7d
‘It’s bonkers’ — how Ozempic, Wegovy change lives of those who struggle to lose weight
The medications are so common now, two-thirds of the clinic’s calls for insurance pre-authorizations are for the big three: ...
health.wusf.usf.edu10d
FDA declares the shortage of obesity drug Zepbound has ended. The results are complicated
The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.
The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using an Off-Brand Version
Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
Fox News14d
FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
Similar to semaglutide treatments like Ozempic and Wegovy, Zepbound activates receptors of hormones secreted from the intestine (GLP-1 and GIP) to reduce appetite and food intake. About 30 million ...
NBC Los Angeles14d
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions – NBC Los Angeles
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.
Bloomberg L.P.14d
We’ve Accepted Wegovy and Zepbound. The Next Phase Is Harder.
This time last year, people were still bickering about whether Novo Nordisk’s Wegovy and Eli Lilly & Co.’s Zepbound represented a shortcut to losing weight or a medical breakthrough.
Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea
Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.